Cardior Pharmaceuticals GmbH

Amgen’s Bradway Decries ‘Innovation Reduction Act’ Amgen, Inc. CEO Bob Bradway has reiterated his concerns about the Inflation Reduction Act and the damaging effect it will have on biotech innovatio

Amgen’s Bradway Decries ‘Innovation Reduction Act’ Amgen, Inc. CEO Bob Bradway has reiterated his concerns about the Inflation Reduction Act and the damaging effect it will have on biotech innovatio

Merger-and-acquisition activity during the first quarter of 2024 was not likely to match the bustling pace of Q4 2023, when the aggregate dollar amount committed to acquisitions topped $52bn and nearl

It is just over 100 years since Novo Nordisk A/S started producing insulin and the Danish company is now on the verge of getting approval for Awiqli, the world's first once-weekly insulin. The Europ